Title [ICAM-1 and allergic inflammation].
Author Canonica, G W
Journal Allerg Immunol (Paris) Publication Year/Month 1997-Mar
PMID 9221016 PMCID -N/A-
Affiliation 1.Departement de Medecine Interne, Universite de Genes, Italie.

Recent progress in the understanding of the physiopathology of asthma makes possible the revision of the objectives of treatment, to pass from short-term symptomatic control to a prolonged control of the illness. L\'ICAM-1 is an excellent potential target for preventative treatment of asthma of viral origin. When there are agents available of both inhibiting histamine and positively regulating ICAM-1 there is no longer reason to use simple antihistamines.

  • Copyright © 2023
    National Institute of Pathogen Biology, CAMS & PUMC, Bejing, China
    All rights reserved.